Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) 80-count bottles (NDC 0363-0131-80) (Walgreens) OTC
Published November 13, 2019 · Recall initiated: October 1, 2019
Summary
FDA records drug Class II recall D-0183-2020, published November 13, 2019 and initiated October 1, 2019. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Completed; Reported quantity: N/A; Lot: Batch Numbers: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of NDMA impurity detected in product.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Product was distributed to major distributors throughout the United States who may have further distributed the product.
- Lot
- Batch Numbers: All lots within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVarenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJDecember 17, 2025
- FDASuccinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, ForOctober 15, 2025
- FDAOmeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy'sJuly 23, 2025
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDARanitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.November 13, 2019
- FDARanitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDCNovember 13, 2019
Questions about this recall
Was Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) 80-count bottles (NDC 0363-0131-80) (Walgreens) OTC recalled?
Yes. FDA published recall D-0183-2020 on November 13, 2019. Reported hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter